Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. Ramos CA, Grover NS, Beaven AW, Lulla PD, et al. J Clin Oncol 2020 Jul 23:JCO2001342. doi: 10.1200/JCO.20.01342.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramos CA, Grover NS, Beaven AW, Lulla PD, et al. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. J Clin Oncol 2020 Jul 23:JCO2001342. doi: 10.1200/JCO.20.01342.
PMID: 32701411